Peritoneal defensins - Key contributors to the innate immunity of the peritoneal cavity?

Peritoneal Dialysis International

Volumn 27, Issue 6, 2007, Pages 634-635

  Faull, Randall ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEFENSIN;

ANTIMICROBIAL ACTIVITY; GENE MAPPING; HUMAN; INNATE IMMUNITY; MESOTHELIUM CELL; NONHUMAN; NOTE; PERITONEAL CAVITY; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; UREMIA; ANIMAL; IMMUNOLOGY;

ANIMALS; DEFENSINS; HUMANS; IMMUNITY, NATURAL; PERITONEAL CAVITY; PERITONITIS;

EID: 41049116181     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700605     Document Type: Note

References (7)

1. Jenssen H, Hamill P, Hancock REW. Peptide antimicrobial agents. Clin Microbiol Rev 2006; 19:491-511.
2. Kapetanovic R, Cavaillon JM. Early events in innate immunity in the recognition of microbial pathogens. Expert Opin Biol Ther 2007; 7:907-18.
3. Batoni G, Maisetta G, Esin S, Campa M. Human beta-defensin-3: a promising antimicrobial peptide. Mini Rev Med Chem 2006; 6:1063-73.
4. Grupp A, Kimmel M, Fritz P, Voggenreiter B, Stöltzing H, Kuhlmann U, et al. The expression patterns of peritoneal defensins. Perit Dial Int 2007; 27:654-62.
5. Zarrinkalam KH, Leavesley DI, Stanley JM, Atkins GJ, Faull RJ. Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis. Perit Dial Int 2001; 21:501-8.
6. Faull RJ. Peritoneal defenses against infection - winning the battle but losing the war? Semin Dial 2000; 13: 47-53.
7. Mortier S, Lameire NH, De Vriese AS. The effects of peritoneal dialysis solutions on peritoneal host defense. Perit Dial Int 2004; 24:123-38.